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Abstract Low-intensity concentric (CET) and eccentric
(EET) endurance-type training induce speciﬁc structural
adaptations in skeletal muscle. We evaluated to which
extent steady-state adaptations in transcript levels are
involved in the compensatory alterations of muscle
mitochondria and myoﬁbrils with CET versus EET at a
matched metabolic exercise intensity of medicated, sta-
ble coronary patients (CAD). Biopsies were obtained
from vastus lateralis muscle before and after 8 weeks of
CET (n=6) or EET (n=6). Transcript levels for factors
involved in mitochondrial biogenesis (PGC-1a, Tfam),
mitochondrial function (COX-1, COX-4), control of
contractile phenotype (MyHC I, IIa, IIx) as well as
mechanical stress marker (IGF-I) were quantiﬁed using
an reverse-transcriptase polymerase chain reaction ap-
proach. After 8 weeks of EET, a reduction of the COX-
4 mRNA level by 41% and a tendency for a drop in
Tfam transcript concentration (33%, P=0.06) was
noted. This down-regulation corresponded to a drop in
total mitochondrial volume density. MyHC-IIa tran-
script levels were speciﬁcally decreased after EET, and
MyHC-I mRNA showed a trend towards a reduction
(P=0.08). Total ﬁber cross-sectional area was not
altered. After CET and EET, the IGF-I mRNA level
was signiﬁcantly increased. The PGC-1a signiﬁcantly
correlated with Tfam, and both PGC-1a and Tfam sig-
niﬁcantly correlated with COX-1 and COX-4 mRNAs.
Post-hoc analysis identiﬁed signiﬁcant interactions
between the concurrent medication and muscular tran-
script levels as well as ﬁber size. Our ﬁndings support the
concept that speciﬁc transcriptional adaptations mediate
the divergent mitochondrial response of muscle cells to
endurance training under diﬀerent load condition and
indicate a mismatch of processes related to muscle
hypertrophy in medicated CAD patients.
Keywords Muscle plasticity Æ Mechanical stress Æ
Metabolic stress Æ mRNA Æ Eccentric exercise
Abbreviations CET: Concentric endurance-type
training Æ EET: Eccentric endurance-type training Æ
RT-PCR: Reverse-transcriptase polymerase chain
reaction
Introduction
Skeletal muscle is a highly adaptive tissue, capable of
altering its contractile and metabolic properties in re-
sponse to repeated bouts of contractile activity. Muscle
responds to mechanical or metabolic signals by adjust-
ing protein synthesis, leading to structural, metabolic
and physiological adaptations (Booth and Thomason
1991). Contractile activity-induced structural adapta-
tions in muscle are highly speciﬁc and depend on the
frequency, intensity, duration and the type of exercise
(see Hoppeler 1986). The magnitude of mechanical,
metabolic and neuronal stimuli in exercise sessions var-
ies according to the type of muscle contraction, as dic-
tated by the force–velocity relationship (Komi 1986).
When a skeletal muscle actively shortens (concentric
contractions), the force produced, and hence the
mechanical stimulus is less than during lengthening
(eccentric) contractions at the same metabolic load. In-
deed, eccentric exercise allows an over fourfold higher
muscle loading than conventional concentric exercise for
the same metabolic demand (Lindstedt et al. 2001). The
eccentric training paradigm hence represents an option
to perform high load muscular exercise training with
small cardiovascular demand (Meyer et al. 2003).
Eccentric training interventions therefore may be of
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beneﬁt for cardiac rehabilitation where hemodynamic
load needs to be tightly controlled.
It was demonstrated that eight weeks of eccentric
endurance-type training (EET) of healthy subjects re-
sulted in a 40% increase in both muscle strength and
cross-sectional area of muscle ﬁbers (LaStayo et al.
2000). Eccentric exercise has been shown to enhance the
gain in muscle strength more than concentric training
alone (Komi and Buskirk 1972; Friden et al. 1983;
Colliander and Tesch 1990; Hortobagyi et al. 1996;
LaStayo et al. 2000). Recently we have analyzed the
eﬀect of EET in stable coronary artery disease (CAD)
patients with essentially normal central and peripheral
performances (Steiner et al. 2004). The study demon-
strated a signiﬁcant increase in the subsarcolemmal
mitochondrial volume density of muscle ﬁber after
concentric endurance-type training (CET) which was
associated with a decrease of myoﬁbril volume density
(Steiner et al. 2004). By contrast, EET produced a
reduction of total mitochondrial volume density with a
concomitant increase of myoﬁbril volume density. Sub-
sarcolemmal mitochondria form the smaller portion of
the mitochondrial population, and are known to be
preferentially increased after CET (Hoppeler et al. 1985;
Hoppeler 1986). These observations support the concept
of a diﬀerential muscular adaptation to CET and EET
(LaStayo et al. 2000).
To date, the molecular mechanisms conferring spec-
iﬁcity for structural and functional modiﬁcations after
concentric and eccentric training are not established. In
particular, the critical links between physical activity,
involving mechanical, metabolic, hormonal and neuro-
nal stress, and changes in muscle cell phenotype are still
unclear (Fluck and Hoppeler 2003). The cumulative ef-
fects of transient increases in transcription during
recovery from consecutive bouts of exercise have been
shown to be the basis for the cellular adaptations asso-
ciated with exercise training (Pilegaard et al. 2000; Fluck
and Hoppeler 2003; Hildebrandt et al. 2003). In fact, in
vitro and in vivo studies have identiﬁed a number of
regulatory and/or signaling pathways with the potential
to modify these fundamental cellular and molecular
processes in skeletal muscles (Booth et al. 1998; Musaro
et al. 1999; Haddad and Adams 2002; Fluck and Hop-
peler 2003; Hoppeler and Fluck 2003). For this study, it
was hypothesized that CET and EET would provoke
divergent adjustments of the transcript level of markers
of mitochondrial metabolism and contractile phenotype
commensurate with the modiﬁcations of muscle ultra-
structure and function observed with these interventions
(Steiner et al. 2004).
To this end we selected mRNAs coding for tran-
scriptional co-activators and transcription factors
implicated in mitochondrial biogenesis (PGC-1a and
Tfam; Hood 2001), for proteins implicated in the
deﬁnition of mitochondrial phenotype (mitochondrial-
and nuclear-encoded subunits of respiratory chain
complex IV [cytochrome oxidase subunit 1 and 4
(COX-1, COX-4); Hood 2001], or related to contractile
phenotype (MyHC I, IIa, IIx) and hypertrophy
[Insulin-like growth factor-I (IGF-I); Bamman et al.
2001]. In view of the ﬁndings of speciﬁc structural
modiﬁcations with CET and EET-training we
hypothesized that the mRNA levels of mitochondrial
factors would be increased after CET while being re-
duced with EET and analyzed whether MyHC type I
and IIa transcript species would be diﬀerently aﬀected
by CET and EET. Furthermore, it was hypothesized
that mRNA expression of factors related to mechani-
cal stress would be selectively increased after training
in EET. Since subjects were under prophylactic medi-
cation with statins and angiotensin-converting enzyme
(ACE) inhibitors known to interfere with mitochon-
drial function (statin; Paiva et al. 2005; Phillips et al.
2002) and muscle hypertrophy (ACE; Gordon et al.
2001) we tested post-hoc whether this had interfered
with the suspected muscular adjustments.
Methods
Subjects and conditioning program
Twelve male patients with stable CAD who were
participating in the out-patient cardiac rehabilitation
program at the University Hospital of Bern were in-
cluded in the study. The study protocol was approved
by the local Ethical Committee on Human Research in
accordance with the terms deﬁned in the Helsinki
convention. All patients gave informed written consent
before participating. They were randomly assigned to
the CET or EET groups. The concentric training was
done on a conventional cycle ergometer and EET was
performed on a custom-built motor-driven ergometer
as described (Steiner et al. 2004). The entire training
period lasted 8 weeks, CET and EET was carried out
three times per week for half an hour. Training was
carried out at the same metabolic exercise intensity for
the EET and the CET group. Exercise intensity was
increased gradually over the ﬁrst 5 weeks of the
rehabilitation program to a level corresponding to
60% of peak oxygen uptake achieved in the ramp test
performed at the entry into the rehabilitation program
(Meyer et al. 2003). Based upon measures of central
and peripheral performance, as assessed by left ven-
tricular ejection fraction and maximal oxygen uptake
(Meyer et al. 2003), the stable CD patients of our
study matched normal active individuals as deﬁned by
clinical and physical deﬁnitions.
Muscle biopsy samples
Using the Bergstrom technique (Hultman and Berg-
strom 1967), biopsies were taken at mid-thigh level from
vastus lateralis muscle before and after the 8-week
training period. Before the biopsies, subjects were min-
imally 48 h without any exercise activity [interval of
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5.5±1.5 (mean ± SEM) days post-training]. The data
presented in this study thus represent steady state
adaptations of concentrations for the RNA species
analyzed. For mRNA analysis, the major part of the
muscle tissue was immediately frozen in isopentane
cooled by liquid nitrogen, and then stored in the latter
until required for analyses. The other part was processed
for electron microscopy and morphometry as described
previously (Steiner et al. 2004).
Morphometry
Ultrastructural alterations of m. vastus lateralis were
determined by morphometric analysis of biopsies as
previously described (Steiner et al. 2004).
Histochemistry
Twelve micrometer cryostat cross-sections were
processed for myoﬁbrillar ATPase (alkaline or acid
pre-incubation at pH 10.4 and pH 4.5) as described
(Billeter et al. 1980). Consistently with the proposition
of Berchtold et al. (2000), the muscle ﬁbers were
classiﬁed into type I, IIA and IIX ﬁbers. The per-
centage of each ﬁber type was obtained from stained
sections. One to three sections from diﬀerent areas of
each muscle biopsy were analyzed, depending on the
size of the specimens. All the ﬁbers that appeared
reasonably cross-sectioned (minor to major ﬁber axis
>0.5) were counted. On average, 178 ﬁbers were
counted per biopsy.
RNA extraction and reverse transcription
Total RNA was extracted from the human vastus
lateralis muscle samples using the RNeasy minikit
(Qiagen AG, Basel, Switzerland) as described (Fluck
et al. 2003). Formaldehyde-Agarose gel analysis dem-
onstrated the integrity of all RNA samples. RNA
aliquots (600 ng) of these reactions were reverse tran-
scribed in 20 ll into cDNA, with 4 U of Reverse
Transcriptase using random hexamer primers (1 lM)
and 0.5 mM dNTPs (=RT-reaction), following the
manufacturer’s instructions (Omniscript Reverse
Transcriptase kit, Qiagen, Basel, Switzerland).
Real-time polymerase chain reaction (PCR) ampli-
ﬁcation reactions were carried out in triplicates on
30 ll aliquots in a 96-well plate with an ABI Prism
5700 Sequence Detection System using cDNA signal
detection via SYBRGreen (PE Biosystem, Rotkreuz,
Switzerland). Primers were designed with the Primer
Express software (PE Biosystems, Rotkreuz, Switzer-
land). Emphasis was put to detect all known splice
forms of these genes in toto. Sequences of the primers
used are given in Table 1. Real-time PCR reactions
with one speciﬁc primer set were conducted on the
same 96-well plate for all samples in parallel. PCR
reactions for level determination of cDNAs encoding
an mRNA (PGC-1a, Tfam, COX-1, COX-4, IGF-I,
MyHC I, IIa, IIx) were carried out with 2 ll aliquots
of a 1:10 dilution of the RT-reaction, whereas the
PCR reactions for the cDNA corresponding to 28S
rRNA were performed with a 1:100 dilution of the
RT-reaction. Care was taken to assay only samples
with the same number of freeze-thaw cycles in the
simultaneous PCR reaction for a transcript. The
amount of target cDNA encoding mRNA relative to
the reference (28S) was calculated using the CT (com-
parative threshold cycle for target ampliﬁcation)
method as described (Fluck et al. 2003).
Speciﬁcity of ampliﬁed cDNA was veriﬁed from the
dissociation curve as determined on the ABI Prism
5700 and by checking the ampliﬁed fragment for cor-
rect size after separation of the PCR reaction on a 1%
Agarose gel. The mean CT values for 28S were not
diﬀerent before and after both training modalities.
28S-related mRNA levels were normalized to the mean
values of the respective training group before the
8 weeks of training.
Statistical analysis
Grubbs test for outliers was applied to test for the
possible qualiﬁcation of extreme data points as outliers
(Grubbs 1969). This revealed that one data point (COX-
1, post EET) was an outlier at a signiﬁcance level of
<0.01. Hence this point was removed from the calcu-
lation of inter-gene correlations of mRNA levels.
Diﬀerences between pre- and post-training values
for absolute 28S-related RNA concentrations, esti-
mates of muscle ultrastructure and muscle ﬁber types
were analyzed using a paired Wilcoxon test. The par-
ticular conditions of the test were chosen dependent on
the hypothesis. With a distinct hypothesis on the
direction of the expressional change a one-tailed test
was applied. In absence of a distinct prognosis a two-
tailed test was used. Interaction of training modality
(CET, EET) or training (pre, post) on transcript levels
was veriﬁed with a two-way analysis of variance
(ANOVA) for repeated measures with Fisher’s least
signiﬁcance diﬀerence post-hoc test. Coeﬃcients of
correlation were calculated using Pearson Product
Moment Correlation for pre- and post-training values
separately. The probability level for statistical signiﬁ-
cance was set at P £ 0.05. An alteration was consid-
ered as a trend at P £ 0.10 and P>0.05. Interaction
eﬀects of each medication with training modality
(CET, EET) and/or training (pre, post) was tested for
each muscular measurement with a 3-way ANOVA.
All statistical analyses were carried out with the Stat-
istica software package 6.1 [StatSoft (Europe) GmbH,
20253 Hamburg, Germany]. For the preparation of
graphical presentations Sigmaplot 2002 vs. 8.0 (SPSS
Inc.) was used.
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Results
Muscle morphometry
Muscle morphological characteristics are reported in
Table 2. With CET, the volume density of total mito-
chondria was unchanged but after EET it was decreased
(20%). The volume density of subsarcolemmal mito-
chondria, increased after CET (+42%) whereas the
volume density of central, but not subsarcolemmal
mitochondria, showed a trend towards a lower level
after EET (17% respectively, P=0.07). As a conse-
quence of these mitochondrial alterations, the volume
densities of myoﬁbrils for both training modalities
changed in opposite direction (4.6 and +2.8% after
CET and EET, respectively). Muscle ﬁber cross-
sectional area showed a trend towards an increase in
CET only (+19%, P=0.08).
Fiber type distribution
The data on ﬁber type distribution is reported in Ta-
ble 3. The initial distribution of ﬁber types in coronary
patients was not diﬀerent between the CET and EET
group. After 8 weeks of EET, the percentage of type IIA
ﬁber was increased (+32%) with no signiﬁcant altera-
tions neither in type I nor IIX ﬁbers. There was no
indication for a change in the ﬁber type composition
after 8 weeks of CET.
mRNA expression analysis
Normalized values obtained for each mRNA level as
determined by reverse-transcriptase polymerase chain
reaction (RT-PCR), before and after 8 weeks of training
are given in Fig. 1.
Mitochondrial biogenesis
PCR quantiﬁcation showed no signiﬁcant changes of the
mRNA level of the transcriptional co-activator PGC-1a
after both training modalities. Tfam, which was not
altered after CET, showed a tendency towards a
decrease of 33% after EET (P=0.06).
Oxidative enzymes
The hypothesis of an increase of the COX-1 and COX-4
mRNA levels after CET was rejected. On the other
hand, after EET, COX-4 was signiﬁcantly decreased by
41% whereas COX-1 remained unchanged. PGC-1a
signiﬁcantly correlated with Tfam, and both Tfam and
PGC-1a correlated signiﬁcantly with COX-1 and COX-
4 mRNA levels (Fig. 2).T
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Mechanical stress pathway
Expression of IGF-I mRNA was signiﬁcantly in-
creased after CET and EET (+31 and +78%,
respectively). When pre-training values from both
groups were combined, the transcript level of IGF-I,
was signiﬁcantly and positively correlated with those
involved in mitochondrial biogenesis, Tfam (r=0.92),
and mitochondrial respiration COX-1 (r=0.83) and
COX-4 (r=0.85). These associations were lost after
both training interventions (not shown).
MyHC isoforms
The hypothesis of increased mRNA levels for either of
the MyHC isoforms was rejected implying that MyHC
Table 3 Fiber type distribution
CET EET
Pre Post Pre Post
% Type I ﬁbers 47.3±4.3 54.5±2.8 48.0±5.3 45.9±3.5
% Type IIA ﬁbers 29.0±3.9 25.9±3.6 24.5±2.0 32.3±1.9*
% Type IIX ﬁbers 23.7±4.0 19.6±1.8 27.6±6.4 21.8±3.3
Values are means ± SEM
Signiﬁcant diﬀerences between pre- and post-training values, *P<0.05
Eccentric Exercise TrainingConcentric Exercise Training
mRNA expression level
0
a b
1 2
*
P =
PGC1
TFAM
COX1
COX4
IGF-I
MHC-I
MHC-IIa
MHC-IIx
0.17
0.12
0.08
0.46
0.05
0.42
0.75
0.46
Pre training Post training
0 1 2
*
†
*
PGC1
TFAM
COX1
COX4
IGF-I
MHC-I
MHC-IIa
MHC-IIx
mRNA expression level
P =
0.46
0.06
0.25
0.02
0.04
0.08
0.04
1.00
*
†
†
Fig. 1 Relative mRNA concentrations for gene products involved
in muscular phenotype deﬁnition before and after concentric (a)
and eccentric (b) endurance-type training. Open bars represent pre
training values and solid bars are post training values of 28S-related
mRNA concentrations in vastus lateralis muscle of coronary
patients. Post-training values were related to the pre-values, which
are set to 1. Data are means ± SEM. *P<0.05 versus before
training. p<0.10 versus before training. Underlined P values refer
to those changes veriﬁed with a one-tailed Wilcoxon test. For gene
names see list of abbreviations
Table 2 Muscle structure before and after 8 weeks of concentric (CET) and eccentric (EET) cycle ergometer training [adapted from
(Steiner et al. 2004)]
CET EET
Pre Post Pre Post
Mitochondria total (%) 5.2±0.7 6.0±0.5 5.3±0.6 4.2±0.3*
Central (%) 4.4±0.5 4.6±0.4 4.4±0.5 3.7±0.2**
Subsarcolemmal (%) 0.8±0.2 1.2±0.2* 0.9±0.2 0.5±0.1
Myoﬁbrils (%) 81.3±1.0 77.5±0.9* 79.6±1.1 81.8±0.7*
Fiber cross-sectional area (lm2) 3,524±216 4,209±417** 4,523±460 4,402±282
Values are means ± SEM
Signiﬁcant diﬀerence to pre-training values, *P<0.05; **P<0.10
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expression remained stable after CET. In contrast,
after EET the MyHC-IIa mRNA level was signiﬁ-
cantly decreased (40%) and MyHC-I showed a trend
towards a reduction (31%, P=0.08). MyHC-IIx
mRNA levels were not altered with either type of
training.
Pre
Post
TFAM
0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
CO
X-
1
0.00
0.50
1.00
2.50
2.75
outlier
r=0.74, p=0.009
r=0.61, p=0.037
TFAM
0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
CO
X-
4
0.0
0.5
1.0
1.5
2.0
2.5
r=0.81, p=0.001
r=0.64, p=0.026
PGC-1
0 2 4 6 8 10
TF
AM
0
1
2
3
4
a
b d
cr=0.76, p=0.004
r=0.78, p=0.003
PGC-1
0 2 4 6 8 10
CO
X-
1
0.00
0.50
1.00
2.50
2.75
outlier
r=0.89, p < 0.001
r=0.54, p=0.07
Fig. 2 Correlations analysis of mRNA levels for factors of
mitochondrial biogenesis. Pearson correlation analysis between
28S-related mRNA concentrations for a PGC-1a and Tfam; b
PGC-1a and mitochondrial DNA-encoded COX-1; c Tfam and
COX-1 and d Tfam and nuclear DNA-encoded COX-4 in vastus
lateralis muscle of coronary patients. Dotted and straight lines
indicate the regression lines for pre- and post-training values.
Correlation coeﬃcient (r) and the level of statistical signiﬁcance
(P) are given beneath each regression line. The data point
indicated by the arrow qualiﬁed as an outlier and was excluded
from the calculated correlation. For gene names see list of
abbreviations
Table 4 Interactions of medicaments with muscular parameters
Pre ACE Statin
MHC-I mRNA 0.06 NS
MHC-IIA mRNA 0.06 NS
Fiber size 0.06 NS
COX-4 mRNA NS 0.10
Pre/post ACE ACE · training Statin
IGF-I mRNA 0.07 NS NS
MHC-I mRNA NS 0.06 NS
MHC-IIA mRNA NS 0.04 NS
Fiber size 0.08 NS 0.05
COX-4 mRNA NS 0.04 0.03
Data were statistically evaluated with a 3-way ANOVA (medicament · training modality · training). Numbers denote P-values
NS not signiﬁcant (P>0.20)
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Eﬀect of medication
There was a signiﬁcant interaction between statin intake
and training-induced alterations of COX-4 mRNA lev-
els as well as ﬁber size (Table 4). Additionally, there was
an interaction eﬀect of ACE–intake · training on COX-
4 with MHC-IIA mRNA as well as there was a trend for
MHC-I mRNA (P=0.06). With regard to the pre-
training state, trends for an eﬀect of ACE-intake were
given for MHC-I, MHC-IIA mRNA as well as for ﬁber
size.
Discussion
Major ﬁndings
This is the ﬁrst study exploring the transcriptional
mechanisms involved in the discrete contractile and
metabolic muscular adaptations of stable coronary pa-
tients to 8 weeks of CET and EET. We assessed the
expression levels of a set of selected mRNAs. RT-PCR
experiments indicate that speciﬁcally after EET there is a
reduction in the expression of the mitochondrial respi-
ratory chain component COX-4, and suggest a de-
creased transcript level of the factor of mitochondrial
biogenesis, Tfam. Both of these transcript alterations are
in accordance with the decrease of the mitochondrial
volume density. Surprisingly, we also found a trend for a
reduction in the expression of genes coding for proteins
implicated in contractile properties (MyHC-I, MyHC-
IIa) after EET. CET and EET increased the mRNA level
of the growth factor IGF-I.
Potential limitations of this pilot study
These are the ﬁrst data on the functional (Meyer et al.
2003), structural (Steiner et al. 2004) and molecular
response (this report) to chronic eccentric exercise
during cardiovascular rehabilitation of CAD patients. In
the design of the study we were therefore limited by
constraints of the experimental protocol imposed by the
ethical committee. This has lead to a number of limita-
tions inherent in our experimental design, which we were
unable to change a priori. We had constraints on patient
selection as well as the ﬁnal workload these patients were
allowed to perform. We were further unable to inﬂuence
medication; hence we are faced with possible interfer-
ences from this pharmacological treatment. Despite
these confounding factors we believe that important
biological information on the adaptive transcriptional
processes activated by eccentric versus concentric train-
ing can be derived from our investigation (see below).
This is of particular importance for patients when con-
sidering recovering from CADs following exercise
rehabilitation. The current set of novel molecular data
thus reﬂects an important complement to the functional
and structural observations published previously.
Increasing the workload more than we were allowed
could amplify the molecular adaptations described to
occur in skeletal muscle after training in this study.
Especially after CET, it is expected that markers of
oxidative metabolism are over-expressed (Puntschart
et al. 1995; Bengtsson et al. 2001; Vogt et al. 2001). The
contention that the unchanged ﬁber size after EET is due
to insuﬃcient hypertrophic stimuli provided with the
eccentric training is supported by the results on ﬁber
cross-sectional area of the CET group (Table 2). With
regard to the measure of mRNA levels in a post-training
steady-state, care was taken to avoid heavy exercise 48 h
prior to the biopsy sampling. However, the extended
time period between the last exercise training and some
biopsies may have led to an underestimation of the pre-
post training diﬀerences in some transcripts. Despite
this, it has been noted that transcripts can be remarkably
stable within the post-exercise period (Simsolo et al.
1993; Pilegaard et al. 2000). In support of this conten-
tion we ﬁnd no eﬀect of time on transcript levels.
Speciﬁc molecular alterations after exercise training
Mitochondrial alterations.
As EET was carried out at a similar systemic metabolic
load as CET but with a nearly fourfold higher
mechanical workload (Meyer et al. 2003), the compari-
son of both training modalities potentially allows to
separate the muscular adaptations resulting from
mechanical and metabolic stress during exercise. After
EET, we showed a speciﬁc drop in COX-4 mRNA level
(i.e., the nuclear-encoded subunit 4 of respiratory chain
complex IV) and a trend (P=0.06) towards a reduced
Tfam transcript concentration. Tfam is crucial for
mitochondrial biogenesis and abundant enough to
activate mitochondrial transcription in a normal state
(Alam et al. 2003; Montoya et al. 1997; Hood 2001;
Adhihetty et al. 2003). The involvement of Tfam in
control of mitochondrial volume and COX-4 mRNA
expression is supported by the observation on a linear
relationship between Tfam mRNA levels and the tran-
script concentration of COX-1 and COX-4 (Fig. 2). This
down-regulation of nuclear-encoded Tfam and COX-
4 mRNA levels after EET implicates that the observed
reduction of volume densities of mitochondria after EET
(Table 2) involves a speciﬁc transcriptional mechanisms.
The drop of mitochondrial volume density does there-
fore not simply result from dilution of a constant
mitochondrial volume in larger muscle ﬁbers (Mac-
Dougall et al. 1979; Luthi et al. 1986). The absence of
signiﬁcant alterations in mitochondria-associated tran-
script levels after CET is explained by the fact that only
the small subpopulation of subsarcolemmal mitochon-
dria but not total or central mitochondrial content was
increased after the concentric training conditions
(Table 2). Because the systemic metabolic load was
similar in CET and EET, these ﬁndings further suggest
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that diﬀerent, i.e., mechano-dependent transcriptional
adaptations mediate the divergent inﬂuence of length-
ening as opposite to shortening contractions on the
metabolic muscular phenotype.
Concerning the involvement of the major positive
factor of muscle mitochondrial biogenesis, PGC-1a (Wu
et al. 1999; Lehman et al. 2000), the results showed a
stable PGC-1a mRNA level after both trainings (Fig. 1).
These results relate to the observation on a similar stea-
dy-state PGC-1a mRNA level in m. vastus lateralis
muscle of untrained and trained legs (Pilegaard et al.
2003). These data do not contradict the suggested role of
PGC-1a in control of the skeletal muscle oxidative
capacity in mammals (Garnier et al. 2003) in as much as
the PGC-1a mRNA level was correlated with expression
of Tfam when compared over all subjects and the train-
ing interventions (Fig. 2). Moreover, in response to
exercise, PGC-1a mRNA increase was transient in both
legs, returning to resting levels 24 h after exercise
(Pilegaard et al. 2003). Since our biopsies were realized
minimally 48 hours after the last exercise, this could be
the reason why the PGC-1amRNA level was not altered.
Contractile alterations
EET leads to a decrease of MyHC-I (P=0.08, trend)
and a drop of MyHC-IIa (P=0.04) mRNA expression
levels whereas their levels remained unchanged after
CET. With regard to the changes in ﬁber size this sup-
ports the notion of translational modiﬁcations or myo-
ﬁbrillar protein turnover changes. Previous work
reported enhanced abundance of ribosomes after
8 weeks of eccentric ergometer training (Friden 1984), a
more eﬃcient mRNA translation after a single bout of
heavy resistance exercise (Chesley et al. 1992) or after a
short resistance exercise training (Welle et al. 1999).
It has been suggested that during periods of increased
loading, myoﬁbers upregulate the expression and secre-
tion of IGF-I (Adams 1998). IGF-I stimulates myo-
ﬁbrillar protein synthesis, satellite cell activation and
consequent myoﬁber hypertrophy in an autocrine/
paracrine fashion (Adams 1998; Musaro et al. 2001).
Hence IGF-I represents a potential hypertrophic agent
which is active during the recovery phase from exercise.
In our study we demonstrated that IGF-I mRNA
expression was signiﬁcantly increased after both training
conditions (Fig. 1). The higher IGF-I mRNA level after
CET suggests that IGF-I expression is not only con-
trolled by acute load-induced damage (Bamman et al.
2001), but also linked to the augmentation of mechani-
cal and metabolic activities in untrained individuals. The
ﬁnding of a tendency for an increase of ﬁber cross-sec-
tional area and IGF-I mRNA expression after the
exercise training protocol with shortening contractions
supports the implication of this growth factor in the
muscular remodeling response following an endurance
training in untrained subjects (McKoy et al. 1999;
Hameed et al. 2003). This increase of IGF-I expression
could be one of the principal transcriptional events with
endurance exercise.
Pathophysiology
The coincident downregulation of gene expressional as
well as structural indicators of the mitochondrial
phenotype in conjunction with the drop in MHC
mRNA levels and the stagnant mean ﬁber size with
eccentric training was a remarkable observation of our
investigation. These adaptations invoke possible nega-
tive eﬀects of the mechanical protocol for the recruited
muscle groups of the studied CAD patients. This is in
contrast to the improvement of volume density of
subsarcolemmal mitochondria in the matched concen-
tric group (see Table 2). In this respect, the CAD
patients under study did from a haemodynamic point
of view not show any signs of central or peripheral
abnormalities under the imposed training conditions
(Meyer et al. 2003). However, recent studies indicate
that the prophylactic treatment against various car-
diovascular risk factors may interfere with muscle
function. For instance, ACE inhibitors and statins can
exert adverse eﬀects on muscle growth (Gordon et al.
2001) and mitochondrial function (Paiva et al. 2005;
Phillips et al. 2002; Thompson et al. 2003). This con-
tention is supported by several signiﬁcant interactions
between statin or ACE use transcript levels as well as
interactions with ﬁber size (Table 4). This suggests that
the concurrent prescription of medicaments (see Meyer
et al. 2003) may have interfered with the expected gain
of ﬁber cross-sectional area post EET. This ﬁnding is
supported by evidence that exercise can unmask neg-
ative eﬀects of statins on muscle in some patients
(Thompson et al. 2003). Collectively, the interactions
indicate that possibly a number of treatments will
interfere with exercise when both are prescribed during
rehabilitation. This constitutes an area worth of fur-
ther study.
Conclusions
Our ﬁndings indicate that muscle tissue reacts speciﬁ-
cally and diﬀerently to the combination of mechanical
and metabolic stress induced by CET and EET in a
population of stable CAD. In particular we observed a
tendency towards a decrease in mRNA levels of TFAM
and COX-4 as well as MyHC-I and -IIa in EET muscles
with a concomitant increased myoﬁbrillar volume den-
sity when the mRNA level of the hypertrophy factor
IGF-I was enhanced. This suggests a transcriptional
regulation for mitochondria and a mismatched hyper-
trophy process in the muscles of the medicated CAD
patients under the mechanical stimulation applied with
the eccentric protocol. This ﬁrst pilot study suggests
important biological information on the adaptive tran-
scriptional processes activated by eccentric vs. concen-
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tric training, which could be of particular importance for
patients when considering their recovering from CADs.
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